Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D Bafaloukos
Vascular Endothelial Growth Factor Polymorphisms and Clinical Outcome in Colorectal Cancer Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal
Vascular Endothelial Growth Factor Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis
Clinical Cancer Research
Cancer Research
Oncology
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Tumoral Cavitation in Colorectal Cancer Patients With Unresectable Lung Metastasis Treated With Bevacizumab and Chemotherapy
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Vascular Endothelial Growth Factor Gene Polymorphisms in Japanese Patients With Sarcoidosis
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Patients With hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated With Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-Based Regimen
Anticancer Research
Medicine
Cancer Research
Oncology
Laparoscopic Colorectal Surgery and Vascular Endothelial Growth Factor
Surgical Endoscopy
Surgery
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Versus Bevacizumab in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
